glp-1 drugs in development Glucagon-like peptide-1 receptor: mechanisms and advances therapy History of glucagon-like peptide-1 receptor
Description
26 The majority (67%) of the patients reviewed had a mean baseline HbA1c of 9.5% when therapy was initiated, which supports the theory of lack of action in response to abnormal findings
* Optum Perks is a sister site of Medical News Today
10.1016/j.dsx.2022.102427 113 SiH.ZhaoL.CaiS.WangK.WangJ.GaoF.et al (2023)
This can lead to fewer blood sugar spikes and a reduced need for additional medications
